Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion therapy with platelets and leukocytes.

N L Luban

    Pediatric Annals
    |June 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Advances in blood products improve leukemia and cancer care, but research is needed for optimal radiation, platelet transfusions, and bone marrow transplant support. Further clinical trials are essential for these pediatric cancer patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Predicting risk of peripartum blood transfusion during vaginal and cesarean delivery: A risk prediction model.

    Journal of neonatal-perinatal medicine·2023
    Same author

    Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components.

    Seminars in hematology·2001
    Same author

    Inflammatory myopathy and hepatitis C in a pediatric patient: role of liver biopsy in evaluating the severity of liver disease.

    Hepatology (Baltimore, Md.)·2001
    Same author

    The transfusion-transmitted viruses in blood transfusion.

    Advances in experimental medicine and biology·2001
    Same author

    Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.

    Transfusion·2001
    Same author

    Low factor VIII recovery in haemophilia A patients without inhibitor titre is not due to the presence of anti-factor VIII antibodies undetectable by the Bethesda assay.

    Haemophilia : the official journal of the World Federation of Hemophilia·2001
    Same journal

    Centering Lived Experience: Inclusive Pediatric Care for Children Who Are Deaf and Hard of Hearing and Their Families.

    Pediatric annals·2026
    Same journal

    From Early Childhood to Adulthood: Implementing Neuroaffirming Health Care for Autistic Individuals.

    Pediatric annals·2026
    Same journal

    Neurodivergence in Medical Education: Current Landscape and Inclusive Future for Pediatrics.

    Pediatric annals·2026
    Same journal

    Neurodiversity and Intellectual Disability: Opportunities and Challenges for Functioning and Participation Across the Life Course.

    Pediatric annals·2026
    Same journal

    Action for Access: Equity for Children With Disabilities in Lowand Middle-Income Countries.

    Pediatric annals·2026
    Same journal

    Rethinking "Healthy" for Every Child: Building Flexible, Family Centered Routines in a Neurodiverse World.

    Pediatric annals·2026
    See all related articles

    Area of Science:

    • Pediatric Oncology
    • Transfusion Medicine
    • Hematology

    Background:

    • Significant advancements in blood component preparation and use have improved supportive care for children with leukemia and solid tumors.
    • Despite progress, critical questions persist regarding optimal blood product utilization and preparation methods.

    Purpose of the Study:

    • To highlight ongoing challenges and research needs in transfusion medicine for pediatric cancer patients.
    • To emphasize the role of blood banks in providing specialized products and driving innovation.

    Main Methods:

    • Review of current practices and identification of areas requiring further investigation.
    • Emphasis on the need for randomized clinical trials and research into specific blood product interventions.

    Related Experiment Videos

    Main Results:

    • Unresolved issues include preventing transfusion-associated graft-versus-host disease, managing alloimmunization to platelet concentrates, and optimizing blood product use before bone marrow transplantation.
    • The effectiveness of leukocyte-poor and allogeneic cryopreserved platelets requires validation through clinical trials.

    Conclusions:

    • Further research into radiation dosages, patient selection, and novel platelet products is crucial.
    • Investigating the impact of pre-transplant blood products on graft rejection is essential for bone marrow transplant recipients.
    • Blood banks play a vital role in supplying and innovating blood products for pediatric cancer care.